AMC 083 / UPCC 12716: Tissue Acquisition for Analysis of Prognostic Factors Immunology and Genetic Progression of HIV-1 Associated Malignancies

  • STATUS
    Recruiting
  • participants needed
    5
Send
Updated on 19 February 2024

Summary

The main purpose of this study is to collect tissue from people diagnosed with HIV-associated cancer. We will use these samples to look for genetic changes associated with HIV- and other virus-related cancers.
This may lead to better ways of preventing, detecting, and treating HIV-associated cancers.

Description

If you agree to take part in this study, you will give a blood sample and a tumor tissue sample. 
We will collect the sample(s) at the same time we draw blood for routine medical treatment. We will collect a small piece of your tumor tissue when we take a biopsy for your medical treatment.
 If there is extra tissue from an earlier biopsy that we can use for this study, we will use a small piece of that tissue.
Giving tumor tissue for this research will not add to your surgery time or add any extra procedures. We will send your tissue back if your doctors need it to run more tests for your medical treatment.


FAQ

You will be asked to participate in this study for up to two years.
During these two years, we will review your office visit notes to document your health status.

Details
Condition N/A
Age 18years - 99years
Clinical Study Identifier01567722
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.